{"id":243,"date":"2011-03-29T16:49:17","date_gmt":"2011-03-29T07:49:17","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2011\/03\/29\/201010\/"},"modified":"2017-09-06T11:47:25","modified_gmt":"2017-09-06T02:47:25","slug":"201010","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20110329243\/","title":{"rendered":"2010\u5e74\uff08\u5e73\u621022\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n
    \n
  1. Ishida Y, Uto H, Okayama A, Tsubouchi H. Biomarker discovery for cancer diagnosis using serum proteomic analysis: from basic research to clinical application. In: Handbook on Mass spectrometry: Instrumentation, Data and Analysis, and Applications (Advances in Chemistry Research), ed. J.K.Lang, pp.75-112 (2010). Nova Science Pub Inc, New York. (April)<\/li>\n<\/ol>\n

    \u3010\u539f\u8457\u3011<\/h4>\n
      \n
    1. Aratake Y, Marutsuka K, Kiyoyama K, Kuribayashi T, Miyamoto T, Yakushiji K, Ohno S, Miyake Y, Sakaguchi T, Kobayashi TK, Okayama A, Tamura K, Ohno E. EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology. Cytopathology. 2010, 21(2), p. 103-110. (Apr.) Epub 2009 Oct 27.<\/li>\n
    2. Watanabe M, Nakahata S, Hamasaki M, Saito Y, Kawano Y, Hidaka T, Yamashita K, Umeki K, Taki T, Taniwaki M, Okayama A, Morishita K. Downregulation of CDKN1A in Adult T-Cell Leukemia\/Lymphoma despite Overexpression of CDKN1A in Human T-Lymphotropic Virus 1-Infected Cell Lines. Journal of Virology. 2010;84:14, p. 6966-6977 (July).<\/li>\n
    3. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Ki-Ryang Koh, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, and Yamaguchi K, for the Joint Study on Predisposing Factors of ATL Development investigators. Human T-cell Leukemia virus type \u2160 (HTLV\u20101) proviral load and disease progression in asymptomatic HTLV\u20101 carriers: a nationwibe prospective study in Japan. BLOOD. 2010, 116(8), p. 1211-1219. (Aug.).<\/li>\n
    4. Kamihira S, Yamano Y, Iwanaga M, Sasaki D, Satake M, Okayama A, Umeki K, Kubota R, Izumo S, Yamaguchi K, Watanabe T. Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: A multi-center study. Cancer Science. 2010, 101(11), p. 2361-7. (Nov.).<\/li>\n
    5. Takenouchi H, Umeki K, Sasaki D, Yamamoto I, Nomura H, Takajo I, Ueno S, Umekita K, Kamihira S, Morishita K, Okayama A. Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers. Int J Cancer. 2011, 128(6), p. 1335-1343. (Mar.).<\/li>\n
    6. \u65e5\u9ad9\u5229\u5f66\uff0c\u4e45\u4fdd\u548c\u7fa9\uff0c\u5742\u53e3\u7fd4\u592a\uff0c\u9ed2\u7530\u5b8f\uff0c\u677e\u672c\u4eae\uff0c\u524d\u7530\u5553\u4e00\uff0c\u5bae\u7530\u7fa9\u53f2\uff0c\u5357\u5bdb\u4e4b\uff0c\u68ee\u7d99\u5247\uff0c\u6ff1\u7802\u91cd\u4ec1.\u3000\u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u52644\u88fd\u5264\u306e\u6cbb\u7642\u52b9\u679c\u306e\u6bd4\u8f03\u3068\u4f7f\u3044\u5206\u3051.\u3000\u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c.\u30002011\uff0c79\uff0cp.\u300028\u201032<\/li>\n<\/ol>\n

      \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
        \n
      1. \u91d1\u5b50\u88d5\u7f8e, \u4e0a\u91ce\u53f2\u6717, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u7de9\u5f90\u306b\u9032\u884c\u6027\u306e\u7b4b\u529b\u4f4e\u4e0b\u306b\u3088\u308a\u767a\u75c7\u3057\u305f\u7b4b\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\uff11\u4f8b.\u3000\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1.\u30002010;30:1,p. 26-32.<\/li>\n
      2. \u5bae\u5185\u4fca\u4e00, \u9577\u53cb\u5b89\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u6885\u5317\u90a6\u5f66, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u5ca1\u5c71\u662d\u5f66. \u30b9\u30c6\u30ed\u30a4\u30c9\u5185\u670d\u4e2d\u306b\u767a\u75c7\u3057\u5438\u5165\u30b9\u30c6\u30ed\u30a4\u30c9\u85ac\u304c\u8457\u52b9\u3057\u305f\u633f\u7ba1\u5f8c\u5589\u982d\u8089\u82bd\u816b. \u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u96d1\u8a8c. 2010;48:7,p. 488-491.(7\u6708)<\/li>\n
      3. \u9577\u53cb\u5b89\u5f18, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30dc\u30bb\u30f3\u30bf\u30f3\u3068\u30b7\u30af\u30ed\u30db\u30b9\u30d5\u30a1\u30df\u30c9\u30d1\u30eb\u30b9\u7642\u6cd5\u306e\u4f75\u7528\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u5408\u4f75\u80ba\u9ad8\u8840\u5727\u75c7\u306e1\u4f8b. Modern Physician. 2010;30:p. 58-60.(10\u6708)<\/li>\n
      4. \u91d1\u5b50\u88d5\u7f8e, \u6885\u5317\u90a6\u5f66, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u30d2\u30c8T\u7d30\u80de\u5411\u6027\u767d\u8840\u75c5\u30a6\u30a4\u30eb\u30b9I\u578b(HTLV-1)\u967d\u6027Sjogren\u75c7\u5019\u7fa4\u306b\u8a8d\u3081\u305fJaccoud\u95a2\u7bc0\u75c7\u306e1\u4f8b. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2011, 31(1), p. 73-79.\uff083\u6708\uff09<\/li>\n
      5. \u5f8c\u8feb\u5b8f\u7d00, \u6885\u5317\u90a6\u5f66, \u677e\u7530\u57fa\u5f18, \u91d1\u5b50\u88d5\u7f8e, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66, \u6a4b\u672c\u795e\u5948, \u5c71\u672c\u7ae0\u4e8c\u6717, \u4e0b\u7530\u548c\u54c9. \u6d88\u5316\u7ba1\u51fa\u8840\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3057\u305fWegener\u8089\u82bd\u816b\u75c7\u306e1\u4f8b. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2011, 31(1), p. 80-86.\uff083\u6708\uff09<\/li>\n<\/ol>\n

        \u3010\u7dcf\u8aac\u3011<\/h4>\n
          \n
        1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66.\u3000\u2163.\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u691c\u67fb\u30fb\u8a3a\u65ad\u3000\u708e\u75c7\u30de\u30fc\u30ab\u30fc\u3000\u3000\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\uff08\u7b2c2\u7248\uff09\uff0d\u5bdb\u89e3\u3092\u76ee\u6307\u3059\u6cbb\u7642\u306e\u65b0\u6642\u4ee3\uff0d\u3000\u65e5\u672c\u81e8\u5e8a\u3000\u5897\u520a\u53f7.\u30002010; 68:\u30005,240-243. (5\u6708)<\/li>\n
        2. \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u7d30\u83cc\u611f\u67d3\u75c7\u8a3a\u65ad\u3068\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3. \u7b2c54\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff1a\u7d30\u83cc\u611f\u67d3\u75c7\u691c\u67fb\u3068\u81e8\u5e8a\u8a3a\u65ad\uff0d\u691c\u67fb\u7d50\u679c\u3092\u3069\u3046\u4f7f\u3046\u304b\uff0d(4) \u81e8\u5e8a\u75c5\u7406. 2010, 58(5), p. 517-522. (5\u6708)<\/li>\n
        3. \u9577\u53cb\u5b89\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u81a0\u539f\u75c5\u3068\u611f\u67d3\u75c7. \u611f\u67d3\u3068\u6297\u83cc\u85ac. 2010, 13(3), p. 261-265. (9\u6708)<\/li>\n
        4. \u9ad8\u57ce\u4e00\u90ce. \u7d30\u83cc\u611f\u67d3\u75c7\u306e\u88dc\u52a9\u7684\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2010;78,9-13.(10\u6708)<\/li>\n
        5. \u5ca1\u5c71\u662d\u5f66, \u6a58\u5ba3\u7965. \u514d\u75ab\u5b66\u7684\u691c\u67fb \u611f\u67d3\u95a2\u9023\u691c\u67fb\u3008\u5fae\u751f\u7269\u306e\u6297\u539f\u30fb\u6297\u4f53\u691c\u67fb\u3009 \u3064\u3064\u304c\u866b\u75c5\u6297\u4f53. \u3053\u308c\u3060\u3051\u306f\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8 \u7b2c8\u96c6. Medicina 2010 \u5897\u520a\u53f7. 2010;47(11),422-423. (10\u6708)<\/li>\n<\/ol>\n

          –<\/p>\n

          \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

          B. \u767a\u8868<\/h3>\n

          \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
            \n
          1. \u7530\u4e2d\u5f26\u4e00, \u5e73\u585a\u96c4\u8061. \u7d50\u6838\u96c6\u56e3\u611f\u67d3\u4e8b\u4f8b\u306b\u304a\u3051\u308bQuantiFERON TB-2G\u3068\u753b\u50cf\u691c\u67fb\u306e\u691c\u8a0e. \u7b2c84\u56de\u3000\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a.\u30002010. (4\u67085-6\u65e5\uff086\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02,\u3000\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
          2. \u9ad8\u57ce\u4e00\u90ce, \u677e\u7530\u57fa\u5f18, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66 , \u4e0a\u91ce\u53f2\u6717, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u81a0\u539f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u7d30\u83cc\u611f\u67d3\u75c7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u6e2c\u5b9a\u306e\u6709\u7528\u6027. \u7b2c84\u56de\u3000\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a.\u30002010. (4\u67085-6\u65e5\uff086\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02,\u3000\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
          3. \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u4e0d\u660e\u71b1\u60a3\u800529\u4f8b\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c107\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a. \u30dd\u30b9\u30bf\u30fc \u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u81a0\u539f\u75c5\u2460. 2010. (4\u67089-11\u65e5\uff089\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          4. \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66,\u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u5f53\u79d1\u306b\u304a\u3051\u308b\u5168\u8eab\u6027\u5f37\u76ae\u75c7\uff08SSc\uff09\u306b\u5408\u4f75\u3057\u305f\u80ba\u75c5\u5909\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c50\u56de\u3000\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a.\u30002010. (4\u670823-25\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02,\u3000\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
          5. \u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u65e5\u9ad9\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u304a\u3051\u308bCD147\u967d\u6027\u5358\u7403\u3068\u30de\u30a4\u30af\u30ed\u30d1\u30fc\u30c6\u30a3\u30af\u30eb\u306e\u81e8\u5e8a\u7684\u610f\u7fa9. \u7b2c54\u56de\u3000\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a.\u30002010. (4\u670822-25\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02,\u3000\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          6. \u65e5\u9ad9\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u0394mHAQ\u7d2f\u7a4d\u78ba\u7387\u5206\u5e03\u3092\u7528\u3044\u305f\u30a8\u30bf\u30cd\u30eb\u30bb\u30d7\u30c8\u306e\u6709\u52b9\u6027\u8a55\u4fa1. \u7b2c54\u56de\u3000\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a.\u30002010. (4\u670822-25\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02,\u3000\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          7. \u65e5\u9ad9\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u306e\u81e8\u5e8a\u52b9\u679c. \u7b2c54\u56de\u3000\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a.\u30002010. (4\u670822-25\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02,\u3000\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          8. \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u65e5\u9ad9\u5229\u5f66. \u591a\u5264\u4f75\u7528\u7642\u6cd5\u306b\u3066\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u6cbb\u7642\u3092\u7d99\u7d9a\u3057\u5f97\u305fNTM\u75c7\u5408\u4f75\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e1\u4f8b. \u7b2c54\u56de\u3000\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a.\u30002010. (4\u670822-25\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02,\u3000\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          9. \u91d1\u5b50\u88d5\u7f8e, \u6885\u5317\u90a6\u5f66, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u6297\u4f53\u967d\u6027\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\u306b\u5408\u4f75\u3057\u305fJaccoud\u95a2\u7bc0\u75c7\u306e1\u4f8b. \u7b2c289\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2010. (5\u670829\u65e5, \u5927\u5206\u770c\u7531\u5e03\u5e02, \u5927\u5206\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n
          10. \u65e5\u9ad8\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u751f\u7269\u5b66\u7684\u88fd\u52644\u88fd\u5264\u306e\u6bd4\u8f03. \u7b2c40\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e3b\u984c\u2160-1\uff62\u5404\u751f\u7269\u5b66\u7684\u88fd\u5264\u306e\u7279\u5fb4\u3068\u4f7f\u3044\u5206\u3051\uff63. 2010. (9\u67084-5\u65e5(4\u65e5\u767a\u8868), \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          11. \u5409\u5f18\u606d\u5b50, \u5c0f\u91ce\u4f38\u4e4b, \u5c71\u4e2d\u7be4\u5fd7, \u59eb\u8def\u5927\u8f14, \u7532\u6590\u6cf0\u6587, \u4e0a\u7530\u7ae0. \u9ad8\u9f62\u767a\u75c7\u306eMPO-ANCA\u967d\u6027Wegener\u8089\u82bd\u816b\u75c7\u306e\u4e00\u4f8b. \u7b2c40\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f33\uff62\u8840\u7ba1\u708e\uff65 \u305d\u306e\u4ed6\uff63. 2010. (9\u67084-5\u65e5(5\u65e5\u767a\u8868), \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          12. \u5f8c\u8feb\u5b8f\u7d00, \u6885\u5317\u90a6\u5f66, \u91d1\u5b50\u88d5\u7f8e, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u6a4b\u672c\u795e\u5948, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u5c71\u672c\u7ae0\u4e8c\u6717, \u9577\u53cb\u5b89\u5f18, \u4e0b\u7530\u548c\u54c9, \u5ca1\u5c71\u662d\u5f66. \u6d88\u5316\u7ba1\u51fa\u8840\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3057\u305fWegener\u8089\u82bd\u816b\u75c7\u306e1\u4f8b. \u7b2c40\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f33\uff62\u8840\u7ba1\u708e\uff65 \u305d\u306e\u4ed6\uff63. 2010. (9\u67084-5\u65e5(5\u65e5\u767a\u8868), \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          13. \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264(\u30a4\u30f3\u30d5\u30ea\u30b7\u30ad\u30de\u30d6, \u30a8\u30bf\u30cd\u30eb\u30bb\u30d7\u30c8)\u3092\u5951\u6a5f\u3068\u3057\u3066\u767a\u75c7\u3057\u305f\u507d\u819c\u6027\u8178\u708e\u306e1\u4f8b. \u7b2c40\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f34\uff62\u611f\u67d3\u75c7\uff65 \u30ea\u30f3\u30d1\u816b\uff63. 2010. (9\u67084-5\u65e5(5\u65e5\u767a\u8868), \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          14. \u9ad8\u57ce\u4e00\u90ce, \u5c71\u672c\u6210\u90ce, \u6885\u6728\u4e00\u7f8e, \u5ca1\u5c71\u662d\u5f66. \u81a0\u539f\u75c5\u60a3\u8005\u306b\u5408\u4f75\u3057\u305f\u611f\u67d3\u75c7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u6e2c\u5b9a\u306e\u6709\u7528\u6027. \u7b2c57\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c(\u30dd\u30b9\u30bf\u30fc), \u81e8\u5e8a\u5316\u5b66\u305d\u306e\u4ed6(1). 2010. (9\u670810-12\u65e5(10\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u4eac\u738b\u30d7\u30e9\u30b6\u30db\u30c6\u30eb)<\/li>\n
          15. \u6885\u6728\u4e00\u7f8e, \u7af9\u30ce\u5185\u535a\u4e4b, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66, \u4f50\u3005\u6728\u5927\u4ecb, \u4e0a\u5e73\u61b2. \u7121\u75c7\u5019\u6027\u30ad\u30e3\u30ea\u30a2\u306b\u304a\u3051\u308b\u6b20\u640d\u578bHTLV-1\u30d7\u30ed\u30a6\u30a4\u30eb\u30b9. \u7b2c57\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c(\u30dd\u30b9\u30bf\u30fc), \u907a\u4f1d\u5b50\u611f\u67d3\u75c7(2). 2010. (9\u670810-12\u65e5(11\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u4eac\u738b\u30d7\u30e9\u30b6\u30db\u30c6\u30eb)<\/li>\n
          16. \u4e0a\u91ce\u53f2\u6717, \u6885\u6728\u4e00\u7f8e, \u91ce\u6751\u5275, \u5c71\u672c\u6210\u90ce, \u7af9\u4e4b\u5185\u535a\u4e4b, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u7121\u75c7\u5019\u6027\u30ad\u30e3\u30ea\u30a2\u306e\u7570\u306a\u308b\u9818\u57df\u306e\u30d7\u30ed\u30a6\u30a4\u30eb\u30b9\u91cf\u306b\u57fa\u3065\u3044\u305f\u611f\u67d3\u7d4c\u8def\u306e\u540c\u5b9a. \u7b2c69\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a \uff0d\u304c\u3093\u5f81\u5727\u3078\u5411\u3051\u3066\u306e\u77e5\u306e\u7d71\u5408\uff0d. \u30dd\u30b9\u30bf\u30fc, HTLV-1 (3). 2010. (9\u670822-24\u65e5(22\u65e5\u767a\u8868), \u5927\u962a\u5e9c\u5927\u962a\u5e02, \u5927\u962a\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          17. \u4e09\u5b85\u5eb7\u4e4b, \u5bae\u672c\u670b\u5e78, \u85ac\u5e2b\u5bfa\u5b8f\u5321, \u5927\u91ce\u7bc0\u4ee3, \u5742\u53e3\u5353\u4e5f, \u8352\u6b66\u516b\u8d77, \u6e05\u5c71\u548c\u662d, \u6817\u6797\u5fe0\u4fe1, \u4e38\u585a\u6d69\u52a9, \u5ca1\u5c71\u662d\u5f66, \u7530\u6751\u548c\u592b, \u5927\u91ce\u82f1\u6cbb. EMMPRIN\u767a\u73fe\u3068\u7532\u72b6\u817a\u4e73\u982d\u764c\u306e\u5206\u5316\u5ea6\u3068\u306e\u95a2\u9023. \u7b2c69\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a \uff0d\u304c\u3093\u5f81\u5727\u3078\u5411\u3051\u3066\u306e\u77e5\u306e\u7d71\u5408\uff0d. \u30dd\u30b9\u30bf\u30fc, \u982d\u9838\u90e8\u304c\u3093 (1). 2010. (9\u670822-24\u65e5(24\u65e5\u767a\u8868), \u5927\u962a\u5e9c\u5927\u962a\u5e02, \u5927\u962a\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          18. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh K, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K (JSPFAD investigators). HTLV-1 proviral load and the relation to disease progression in carriers: a nationwide cohort study (OS-3-147). The 72nd Annual Meeting of the Japanese Society of Hematology. 2010. (September 24-26, Japan Kanagawa-ken Yokohama, PACIFICO YOKOHAMA)<\/li>\n
          19. \u771e\u934b\u9999\u6f84, \u9ad8\u677e\u5c1a\u6587, \u4e38\u585a\u6d69\u52a9, \u65e5\u9ad8\u667a\u5fb3, \u4e2d\u7551\u65b0\u543e, \u524d\u7530\u5b8f\u4e00, \u658e\u85e4\u7950\u4ecb, \u6ff1\u5d0e\u8aa0, \u4e00\u30ce\u702c\u5b5d\u5b50, \u5ca9\u7530\u55ac\u5b50, \u7560\u5c71\u91d1\u592a, \u9d5c\u98fc\u7531\u7bc4, \u5ca1\u5c71\u662d\u5f66, \u9ed2\u6ca2\u4ec1, \u6d45\u7530\u7950\u58eb\u90ce, \u5b87\u90fd\u5bae\u8207, \u68ee\u4e0b\u548c\u5e83. CADM1 \u7279\u7570\u6297\u4f53\u3092\u7528\u3044\u305fATLL(\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5\u30fb\u30ea\u30f3\u30d1\u816b)\u8a3a\u65ad\uff65 \u6cbb\u7642\u6cd5\u306e\u958b\u767a. \u7b2c72\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u512a\u79c0\u30dd\u30b9\u30bf\u30fc. 2010. (9\u670824-26\u65e5\uff0825\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c \u4f1a\u8b70\u30bb\u30f3\u30bf\u30fc\u5c55\u793a\u30db\u30fc\u30ebA)<\/li>\n
          20. \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5b88\u7530\u653f\u5ba3, \u7dd2\u65b9\u967d\u4e00, \u67da\u6728\u5d0e\u667a\u5b50, \u65e5\u9ad8\u771f\u7f8e\u5b50, \u5ca1\u5c71\u662d\u5f66. \u75c5\u9662\u518d\u6574\u5099\u306b\u3068\u3082\u306a\u3046\u4e2d\u592e\u63a1\u8840\u5ba4\u306e\u6539\u5584. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u3000\u7b2c42\u56de\u5927\u4f1a. \u4e00\u822c\u6f14\u984c, \u691c\u4f53\u63a1\u53d6\uff65\u524d\u51e6\u7406. 2010. (10\u67087\uff0d9\u65e5\uff089\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          21. \u7530\u4e2d\u5f26\u4e00, \u5e73\u585a\u96c4\u8061. \u7d50\u6838\u96c6\u56e3\u611f\u67d3\u4e8b\u4f8b\u306b\u304a\u3051\u308b\u3001\u7d50\u6838\u6cbb\u7642\u306b\u4f34\u3046QuantiFERON TB-2G\u306e\u63a8\u79fb. \u7b2c80\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c, \u6297\u9178\u83cc\u611f\u67d3\u75c7(2). 2010. (11\u670819-20\u65e5(19\u65e5\u767a\u8868), \u611b\u5a9b\u770c\u677e\u5c71\u5e02, \u677e\u5c71\u5e02\u7dcf\u5408\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          22. \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u6885\u5317\u90a6\u5f66, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u8840\u7cd6\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u4e0d\u826f\u306e\u7cd6\u5c3f\u75c5\u306b\u5408\u4f75\u3057\u305f\u9f3b\u8133\u30e0\u30fc\u30b3\u30eb\u75c7\u306e\u4e00\u4f8b. \u7b2c80\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c, \u771f\u83cc\u611f\u67d3\u75c7(2). 2010. (11\u670819-20\u65e5(20\u65e5\u767a\u8868), \u611b\u5a9b\u770c\u677e\u5c71\u5e02, \u677e\u5c71\u5e02\u7dcf\u5408\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          23. \u95a2\u826f\u4e8c, \u5c71\u53e3\u54f2\u6717, \u9577\u53cb\u5b89\u5f18, \u677e\u672c\u7d2b\u6717. \u5bae\u5d0e\u770c\u4e0b\u306e\u304a\u3051\u308b\u6c17\u7ba1\u652f\u5598\u606f\u60a3\u8005\u5b9f\u614b\u8abf\u67fb10\u5e74\u9593\u306e\u307e\u3068\u3081. \u7b2c60\u56de\u65e5\u672c\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a. \u30dd\u30b9\u30bf\u30fc, \u5598\u606f\u7d71\u8a08. 2010. (11\u670825-27\u65e5(27\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          24. \u4f50\u85e4\u667a\u4ee3, \u9ad8\u57ce\u4e00\u90ce, \u91d1\u5b50\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u6a4b\u5834\u5f25\u751f, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66, \u4e38\u5c71\u6cbb\u5f66, \u72e9\u91ce\u7e41\u4e4b, \u6e21\u908a\u6d69. \u5178\u578b\u7684\u306a\u71b1\u578b\u3088\u308a\u56db\u65e5\u71b1\u30de\u30e9\u30ea\u30a2\u3092\u8003\u616e\u3057\u3001\u8a3a\u65ad\u306b\u81f3\u3063\u305f1\u4f8b. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a \u7b2c292\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u4e00\u822c\u6f14\u984c, \u611f\u67d3\u75c72. 2011. (1\u670829\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          25. \u4f50\u4f2f\u88d5\u4e8c, \u6b66\u7530\u5c55\u5e78, \u6cb3\u91ce\u6e80\u5b50, \u5cf6\u7530\u96c5\u5df3, \u6885\u6728\u4e00\u7f8e, \u5ca1\u5c71\u662d\u5f66, \u4e09\u6fa4\u5c1a\u660e.
            \n\u8840\u6db2\u57f9\u990a\u306b\u304a\u3051\u308bHelicobacter cinaedi \u691c\u51fa\u306e\u7559\u610f\u70b9. \u7b2c22\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a \u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u4e00\u822c\u6f14\u984c\u2161, \u611f\u67d3\/\u5fae\u751f\u7269.2011. (2\u670812\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          26. \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u6cb3\u91ce\u6e80\u5b50, \u5cf6\u7530\u96c5\u5df3, \u6885\u6728\u4e00\u7f8e, \u5f8c\u8feb\u5b8f\u7d00, \u4f0a\u9054\u6674\u5f66,
            \n\u5ca1\u5c71\u662d\u5f66. \u6557\u8840\u75c7\u30fb\u591a\u81d3\u5668\u4e0d\u5168\u3092\u6765\u3057\u305fCapnocytophaga canimorsus \u611f\u67d3\u75c7\u306e1\u75c7\u4f8b. \u7b2c22\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a \u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u4e00\u822c\u6f14\u984c\u2161, \u611f\u67d3\/\u5fae\u751f\u7269.\u30002011. (2\u670812\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          27. \u5c3e\u65b9\u7f8e\u5e78, \u9234\u6728\u5343\u4ee3\u5b50, \u5ddd\u4e0a\u6075, \u5c71\u672c\u667a\u7f8e, \u6885\u6728\u4e00\u7f8e, \u5927\u585a\u73e0\u7f8e, \u9ad8\u6728\u7d14\u4e00,
            \n\u5ca1\u5c71\u662d\u5f66. \u03b2\u2010blocker\u6295\u4e0e\u4e0b\u30019\u5e74\u9593\u7121\u75c7\u72b6\u3067\u7d4c\u904e\u3057\u305f\u5f8c\u3001\u5931\u795e\u30fbTorsabe de pointes\u3092\u8a8d\u3081\u305f\u5f27\u767a\u6027QT\u5ef6\u9577\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c22\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a \u7b2c56\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u4e00\u822c\u6f14\u984c\u2163, \u5faa\u74b0\u5668.\u30002011. (2\u670812\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          28. \u798f\u7530\u771f\u5f13, \u6b66\u7530\u5343\u7a42, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u6d41\u884c\u6027\u89d2\u7d50\u819c\u708e\u306e\u9662\u5185\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u5bfe\u5fdc. \u7b2c26\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c, \u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af4. 2011. (2\u670818-19\u65e5(19\u65e5\u767a\u8868), \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c)<\/li>\n
          29. \u65e5\u9ad8\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u5742\u53e3\u7fd4\u592a, \u9ed2\u7530\u5b8f, \u677e\u672c\u4eae, \u6ff1\u7802\u91cd\u4ec1, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u9ad8\u9f62\u8005\u306b\u5bfe\u3059\u308b\u6297TNF\u88fd\u5264\u306e\u6cbb\u7642\u52b9\u679c\u3068\u5b89\u5168\u6027. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.
            \n\u4e3b\u984c\u2160\u300c\u9ad8\u9f62\u8005\u30fb\u5408\u4f75\u75c7\u30fb\u6a5f\u80fd\u969c\u5bb3\u3092\u6709\u3059\u308bRA\u60a3\u8005\u306e\u6cbb\u7642: \u6574\u5f62\u5916\u79d1\u306e\u7acb\u5834\u304b\u3089, \u5185\u79d1\u306e\u7acb\u5834\u304b\u3089\u300d, \u6f14\u984c1. 2011. (3\u670819-20\u65e5(19\u65e5\u767a\u8868), \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n
          30. \u6885\u5317\u90a6\u5f66, \u6ff1\u7530\u6d69\u6717, \u5ca1\u5c71\u662d\u5f66, \u5e16\u4f50\u60a6\u7537. \u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u751f\u7269\u5b66\u7684\u88fd\u5264\u4f7f\u7528\u5b9f\u614b\u8abf\u67fb. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f31\u300cRA: \u9ad8\u9f62\u8005\u30fb\u5408\u4f75\u75c7\u7b49\u300d, \u6f14\u984c45. 2011. (3\u670819-20\u65e5(19\u65e5\u767a\u8868), \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n
          31. \u4e45\u4fdd\u548c\u7fa9, \u65e5\u9ad8\u5229\u5f66, \u5742\u53e3\u7fd4\u592a, \u9ed2\u7530\u5b8f, \u677e\u672c\u4eae, \u524d\u7530\u5553\u4e00, \u6ff1\u7802\u91cd\u4ec1. \u5408\u4f75\u75c7\u306e\u305f\u3081\u751f\u7269\u5b66\u7684\u88fd\u5264\u5c0e\u5165\u56f0\u96e3\u306a\u75c7\u4f8b\u306b\u5bfe\u3057\u3066\u767d\u8840\u7403\u9664\u53bb\u7642\u6cd5\u304c\u6709\u52b9\u3067\u3042\u3063\u305f3\u4f8b. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f31\u300cRA: \u9ad8\u9f62\u8005\u30fb\u5408\u4f75\u75c7\u7b49\u300d, \u6f14\u984c47. 2011. (3\u670819-20\u65e5(19\u65e5\u767a\u8868), \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n
          32. \u91d1\u5b50\u88d5\u7f8e, \u6885\u5317\u90a6\u5f66, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u80f8\u8179\u90e8\u5927\u52d5\u8108\u75c5\u5909\u3092\u5448\u3057\u305fANCA\u95a2\u9023\u8840\u7ba1\u708e. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f35\u300c\u8840\u7ba1\u708e\u30fb\u5f37\u76f4\u6027\u810a\u690e\u708e\u7b49\u300d, \u6f14\u984c72.2011. (3\u670819-20\u65e5(19\u65e5\u767a\u8868), \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n
          33. \u5742\u53e3\u7fd4\u592a, \u4e45\u4fdd\u548c\u7fa9, \u65e5\u9ad8\u5229\u5f66, \u9ed2\u7530\u5b8f, \u6ff1\u7802\u91cd\u4ec1, \u524d\u7530\u5553\u4e00, \u5357\u5bdb\u4e4b, \u798f\u5cf6\u5065\u81ea, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u5ca1\u5c71\u662d\u5f66. \u56a5\u4e0b\u969c\u5bb3\u3092\u4f34\u3063\u305f\u91cd\u75c7\u76ae\u819a\u7b4b\u708e\u306b\u5bfe\u3057\u3066\u7d4c\u5185\u8996\u93e1\u7684\u80c3\u763b\u9020\u8a2d\u8853\u304c\u6709\u52b9\u3067\u3042\u3063\u305f2\u4f8b. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f39\u300c\u76ae\u819a\u7b4b\u708e\u30fb\u6210\u4eba\u767a\u75c7\u30b9\u30c1\u30eb\u75c5\u7b49\u300d, \u6f14\u984c97. 2011. (3\u670819-20\u65e5(20\u65e5\u767a\u8868),\u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n
          34. \u6a4b\u5834\u5f25\u751f, \u6885\u5317\u90a6\u5f66, \u91d1\u5b50\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u4e0a\u91ce\u53f2\u6717,\u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u86cb\u767d\u6f0f\u51fa\u6027\u80c3\u8178\u708e\u3068\u9593\u8cea\u6027\u80ba\u708e\u3092\u5408\u4f75\u3057\u305f\u76ae\u819a\u7b4b\u708e\u306e1\u4f8b. \u7b2c41\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f39\u300c\u76ae\u819a\u7b4b\u708e\u30fb\u6210\u4eba\u767a\u75c7\u30b9\u30c1\u30eb\u75c5\u7b49\u300d, \u6f14\u984c98. 2011. (3\u670819-20\u65e5(20\u65e5\u767a\u8868),\u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n<\/ol>\n

            \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n

            –<\/p>\n

            \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

            C. \u305d\u306e\u4ed6<\/h3>\n
              \n
            1. \u5ca1\u5c71\u662d\u5f66. \u6bcd\u5150\u611f\u67d3\u5224\u5b9a\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a. \u7814\u7a76\u958b\u767a\u8cc7\u6e90\u6d3b\u7528\u578b, \u7814\u7a76\u30c6\u30fc\u30de\u300c\u767a\u75c7\u5371\u967a\u5ea6\u5224\u5225\u306b\u3088\u308bATL\u767a\u75c7\u30ea\u30b9\u30af\u8a3a\u65ad\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a\u300d\u5171\u540c\u7814\u7a76\u63a8\u9032\u59d4\u54e1\u4f1a. 2010. (10\u670825\u65e5, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u5927\u5b66\u533b\u5b66\u90e8\u9db4\u9675\u4f1a\u9928)<\/li>\n<\/ol>\n
              \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

              D. \u7279\u8a31\u51fa\u9858<\/h3>\n
                \n
              1. \u5ca1\u5c71\u662d\u5f66. \u51fa\u9858\u756a\u53f7 \u7279\u98582010-107627\u3000\u51fa\u9858\u65e5\u30002010\/05\/07\u3000\u51fa\u9858\u4eba \u56fd\u7acb\u5927\u5b66\u6cd5\u4eba\u5bae\u5d0e\u5927\u5b66\u3000\u767a\u660e\u306e\u540d\u79f0\u3000\u30d2\u30c8T\u7d30\u80de\u767d\u8840\u75c5\u30a6\u30a4\u30eb\u30b9(HTLV-1)\u611f\u67d3\u7d4c\u8def\u5224\u5b9a\u65b9\u6cd5\u3001HTLV-1\u6e2c\u5b9a\u7528\u6a19\u6e96\u30d7\u30e9\u30b9\u30df\u30c9\u3001\u305d\u308c\u3092\u7528\u3044\u305f\u6e2c\u5b9a\u65b9\u6cd5<\/li>\n<\/ol>\n

                <\/p>\n

                –<\/p>\n

                \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

                \u5185\u8a33\u6570\uff084\u670830\u65e5\u6642\u70b9\uff09<\/h2>\n

                A.\u8ad6\u6587\uff1a\u8457\u66f8(1)\u3001\u539f\u8457\uff086\uff09\u3001\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\uff085\uff09\u3001\u7dcf\u8aac\uff085\uff09\u3000B.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0834\uff09\u3001\u305d\u306e\u4ed6\uff080\uff09 C.\u305d\u306e\u4ed6\uff081\uff09\u3000D.\u7279\u8a31\u51fa\u9858\uff081\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

                A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 Ishida Y, Uto H, Okayama A, Tsubouchi H. Biomarker discovery for cancer diagnosis using serum prote […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/243"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=243"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/243\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=243"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}